Recent data suggest that DHRS4-AS1 is a tumor inhibitor in clear cell renal cell carcinoma (ccRCC), demonstrating that DHRS4-AS1 is a potential prognostic biomarker in ccRCC (32). Here, DHRS4 is linked to neoplasm.